A citation-based method for searching scientific literature


List of co-cited articles
157 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Glucose-independent improvement of vascular dysfunction in experimental sepsis by dipeptidyl-peptidase 4 inhibition.
Swenja Kröller-Schön, Maike Knorr, Michael Hausding, Matthias Oelze, Alexandra Schuff, Richard Schell, Stephan Sudowe, Alexander Scholz, Steffen Daub, Susanne Karbach,[...]. Cardiovasc Res 2012
130
24

DPP-4 inhibitor linagliptin ameliorates cardiovascular injury in salt-sensitive hypertensive rats independently of blood glucose and blood pressure.
Nobutaka Koibuchi, Yu Hasegawa, Tetsuji Katayama, Kensuke Toyama, Ken Uekawa, Daisuke Sueta, Hiroaki Kusaka, MingJie Ma, Takashi Nakagawa, Bowen Lin,[...]. Cardiovasc Diabetol 2014
38
20

Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease.
Thomas Nyström, Mark K Gutniak, Qimin Zhang, Fan Zhang, Jens Juul Holst, Bo Ahrén, Ake Sjöholm. Am J Physiol Endocrinol Metab 2004
492
20

Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways.
Kiwon Ban, M Hossein Noyan-Ashraf, Judith Hoefer, Steffen-Sebastian Bolz, Daniel J Drucker, Mansoor Husain. Circulation 2008
734
20

Exenatide Protects Against Glucose- and Lipid-Induced Endothelial Dysfunction: Evidence for Direct Vasodilation Effect of GLP-1 Receptor Agonists in Humans.
Juraj Koska, Michelle Sands, Camelia Burciu, Karen M D'Souza, Kalyani Raravikar, James Liu, Seth Truran, Daniel A Franco, Eric A Schwartz, Dawn C Schwenke,[...]. Diabetes 2015
72
16


Acute DPP-4 inhibition modulates vascular tone through GLP-1 independent pathways.
Zubair Shah, Colleen Pineda, Thomas Kampfrath, Andrei Maiseyeu, Zhekang Ying, Ira Racoma, Jeffrey Deiuliis, Xiaohua Xu, Qinghua Sun, Susan Moffatt-Bruce,[...]. Vascul Pharmacol 2011
119
16

Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-4.
Masayuki Arakawa, Tomoya Mita, Kosuke Azuma, Chie Ebato, Hiromasa Goto, Takashi Nomiyama, Yoshio Fujitani, Takahisa Hirose, Ryuzo Kawamori, Hirotaka Watada. Diabetes 2010
355
16

Interactions of DPP-4 and integrin β1 influences endothelial-to-mesenchymal transition.
Sen Shi, Swayam Prakash Srivastava, Megumi Kanasaki, Jianhua He, Munehiro Kitada, Takako Nagai, Kyoko Nitta, Susumu Takagi, Keizo Kanasaki, Daisuke Koya. Kidney Int 2015
96
16

Beneficial effects of GLP-1 on endothelial function in humans: dampening by glyburide but not by glimepiride.
Ananda Basu, Nisha Charkoudian, William Schrage, Robert A Rizza, Rita Basu, Michael J Joyner. Am J Physiol Endocrinol Metab 2007
175
16


Vildagliptin improves endothelium-dependent vasodilatation in type 2 diabetes.
Pleun C M van Poppel, Mihai G Netea, Paul Smits, Cees J Tack. Diabetes Care 2011
102
12

Leptin-induced endothelium-dependent vasorelaxation of peripheral arteries in lean and obese rats: role of nitric oxide and hydrogen sulfide.
Anna Jamroz-Wiśniewska, Arieh Gertler, Gili Solomon, Mark E Wood, Matthew Whiteman, Jerzy Bełtowski. PLoS One 2014
39
12


Glucagon-like peptide 1 prevents reactive oxygen species-induced endothelial cell senescence through the activation of protein kinase A.
Hisko Oeseburg, Rudolf A de Boer, Hendrik Buikema, Pim van der Harst, Wiek H van Gilst, Herman H W Silljé. Arterioscler Thromb Vasc Biol 2010
183
12


Anagliptin, a DPP-4 inhibitor, suppresses proliferation of vascular smooth muscles and monocyte inflammatory reaction and attenuates atherosclerosis in male apo E-deficient mice.
Nasib Ervinna, Tomoya Mita, Eisuke Yasunari, Kosuke Azuma, Rica Tanaka, Satoshi Fujimura, Dewi Sukmawati, Takashi Nomiyama, Akio Kanazawa, Ryuzo Kawamori,[...]. Endocrinology 2013
125
12


Pleiotropic effects of the dipeptidylpeptidase-4 inhibitors on the cardiovascular system.
Annayya R Aroor, James R Sowers, Guanghong Jia, Vincent G DeMarco. Am J Physiol Heart Circ Physiol 2014
74
12

Cardiovascular effects of gliptins.
André J Scheen. Nat Rev Cardiol 2013
120
12


Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.
Benjamin M Scirica, Deepak L Bhatt, Eugene Braunwald, P Gabriel Steg, Jaime Davidson, Boaz Hirshberg, Peter Ohman, Robert Frederich, Stephen D Wiviott, Elaine B Hoffman,[...]. N Engl J Med 2013
12

Alogliptin after acute coronary syndrome in patients with type 2 diabetes.
William B White, Christopher P Cannon, Simon R Heller, Steven E Nissen, Richard M Bergenstal, George L Bakris, Alfonso T Perez, Penny R Fleck, Cyrus R Mehta, Stuart Kupfer,[...]. N Engl J Med 2013
12

DPP4 inhibition attenuates filtration barrier injury and oxidant stress in the zucker obese rat.
Ravi Nistala, Javad Habibi, Annayya Aroor, James R Sowers, Melvin R Hayden, Alex Meuth, William Knight, Tamara Hancock, Thomas Klein, Vincent G DeMarco,[...]. Obesity (Silver Spring) 2014
55
12

Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.
Jennifer B Green, M Angelyn Bethel, Paul W Armstrong, John B Buse, Samuel S Engel, Jyotsna Garg, Robert Josse, Keith D Kaufman, Joerg Koglin, Scott Korn,[...]. N Engl J Med 2015
12

The biology of incretin hormones.
Daniel J Drucker. Cell Metab 2006
12

The novel DPP-4 inhibitors linagliptin and BI 14361 reduce infarct size after myocardial ischemia/reperfusion in rats.
Berthold Hocher, Yuliya Sharkovska, Michael Mark, Thomas Klein, Thiemo Pfab. Int J Cardiol 2013
66
12

Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction.
Jacob Lønborg, Niels Vejlstrup, Henning Kelbæk, Hans Erik Bøtker, Won Yong Kim, Anders B Mathiasen, Erik Jørgensen, Steffen Helqvist, Kari Saunamäki, Peter Clemmensen,[...]. Eur Heart J 2012
380
12


Dipeptidyl peptidase-4 inhibitor, linagliptin, ameliorates endothelial dysfunction and atherogenesis in normoglycemic apolipoprotein-E deficient mice.
Hotimah Masdan Salim, Daiju Fukuda, Yasutomi Higashikuni, Kimie Tanaka, Yoichiro Hirata, Shusuke Yagi, Takeshi Soeki, Michio Shimabukuro, Masataka Sata. Vascul Pharmacol 2016
39
12

The expression and function of Ca(2+)-sensing receptors in rat mesenteric artery; comparative studies using a model of type II diabetes.
A H Weston, M Absi, E Harno, A R Geraghty, D T Ward, M Ruat, R H Dodd, P Dauban, G Edwards. Br J Pharmacol 2008
48
12

GLP-1 and related peptides cause concentration-dependent relaxation of rat aorta through a pathway involving KATP and cAMP.
Brian D Green, Katharine V Hand, Janette E Dougan, Bronagh M McDonnell, Roslyn S Cassidy, David J Grieve. Arch Biochem Biophys 2008
114
12

Endothelial dysfunction in diabetes.
A S De Vriese, T J Verbeuren, J Van de Voorde, N H Lameire, P M Vanhoutte. Br J Pharmacol 2000
841
12


Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy.
Lazaros A Nikolaidis, Dariush Elahi, Teresa Hentosz, Aaron Doverspike, Rhonda Huerbin, Lee Zourelias, Carol Stolarski, You-tang Shen, Richard P Shannon. Circulation 2004
389
12


Dipeptidyl peptidase 4 inhibitor sitagliptin protects endothelial function in hypertension through a glucagon-like peptide 1-dependent mechanism.
Limei Liu, Jian Liu, Wing Tak Wong, Xiao Yu Tian, Chi Wai Lau, Yi-Xiang Wang, Gang Xu, Yunfei Pu, Zhiming Zhu, Aimin Xu,[...]. Hypertension 2012
138
12

A dipeptidyl peptidase-4 inhibitor, des-fluoro-sitagliptin, improves endothelial function and reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice.
Junichi Matsubara, Seigo Sugiyama, Koichi Sugamura, Taishi Nakamura, Yukio Fujiwara, Eiichi Akiyama, Hirofumi Kurokawa, Toshimitsu Nozaki, Keisuke Ohba, Masaaki Konishi,[...]. J Am Coll Cardiol 2012
209
12


Dipeptidyl peptidase-4 inhibitors attenuate endothelial function as evaluated by flow-mediated vasodilatation in type 2 diabetic patients.
Makoto Ayaori, Naotsugu Iwakami, Harumi Uto-Kondo, Hiroki Sato, Makoto Sasaki, Tomohiro Komatsu, Maki Iizuka, Shunichi Takiguchi, Emi Yakushiji, Kazuhiro Nakaya,[...]. J Am Heart Assoc 2013
92
12

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Steven P Marso, Gilbert H Daniels, Kirstine Brown-Frandsen, Peter Kristensen, Johannes F E Mann, Michael A Nauck, Steven E Nissen, Stuart Pocock, Neil R Poulter, Lasse S Ravn,[...]. N Engl J Med 2016
12

Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV.
Anne-Marie Lambeir, Christine Durinx, Simon Scharpé, Ingrid De Meester. Crit Rev Clin Lab Sci 2003
628
12


Antidiabetic Drug Alogliptin Protects the Heart Against Ischemia-reperfusion Injury Through GLP-1 Receptor-dependent and Receptor-independent Pathways Involving Nitric Oxide Production in Rabbits.
Shinya Baba, Masamitsu Iwasa, Kenshi Higashi, Shingo Minatoguchi, Yoshihisa Yamada, Hiromitsu Kanamori, Masanori Kawasaki, Kazuhiko Nishigaki, Shinya Minatoguchi. J Cardiovasc Pharmacol 2017
5
60

AGE/RAGE produces endothelial dysfunction in coronary arterioles in type 2 diabetic mice.
Xue Gao, Hanrui Zhang, Ann Marie Schmidt, Cuihua Zhang. Am J Physiol Heart Circ Physiol 2008
118
8

Resistin decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells.
Changyi Chen, Jun Jiang, Jian-Ming Lü, Hong Chai, Xinwen Wang, Peter H Lin, Qizhi Yao. Am J Physiol Heart Circ Physiol 2010
119
8

Visfatin impairs endothelium-dependent relaxation in rat and human mesenteric microvessels through nicotinamide phosphoribosyltransferase activity.
Susana Vallejo, Tania Romacho, Javier Angulo, Laura A Villalobos, Elena Cercas, Alejandra Leivas, Elena Bermejo, Raffaele Carraro, Carlos F Sánchez-Ferrer, Concepción Peiró. PLoS One 2011
47
8

Protein kinase A mediates glucagon-like peptide 1-induced nitric oxide production and muscle microvascular recruitment.
Zhenhua Dong, Weidong Chai, Wenhui Wang, Lina Zhao, Zhuo Fu, Wenhong Cao, Zhenqi Liu. Am J Physiol Endocrinol Metab 2013
44
8




Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.